The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corp. (BAC), ...

Manufacturing and non-clinical toxicology packages are in development for the ... you may sometimes be able to amend or alter expression and SPINRAZA is a good experience of using an ASO to ...

Biogen's (BIIB) Multiple Sclerosis Sales Fall, New Drugs Aid Sales of multiple sclerosis drugs and Spinraza are declining ... to a decline in the volume of packages shipped. High labor costs ...

Spinraza royalties and payments from collaboration ... We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

In 2016, Spinraza became the first approved treatment for SMA, with exceptional results in infants with severe SMA – so exceptional, it was considered unethical to continue enrolling children ...

There was no treatment until Doctor Adrian Krainer with Cold Spring Harbor lab on Long Island led the way to creation of Spinraza, a first FDA-approved treatment for Spinal Muscular Atrophy.

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corp. (BAC ...

Spinal muscular atrophy (SMA) therapy Spinraza has been a key earner for Biogen in recent years, but with sales now heading into reverse, the company is looking to extend its franchise.

BRISBANE, Australia and NEW YORK, March 11, 2025 /PRNewswire/ -- WearOptimo, a healthcare technology company developing next-generation Microwearable sensors for hydration and biomarker monitoring ...

Spinraza (nusinersen) treatment may help restore balance to the levels of some lipids, fat-like molecules that are lower in the cerebrospinal fluid (CSF) of children with spinal muscular atrophy (SMA) ...